Resources
- Summary of Molecular Glues Approved or in Clinical Trial
- FDA Approved First HER2/HER3 Bispecific Antibody - Zenocutuzumab (Bizengri)
- Three ADCs Expected To Be Approved In 2024-2025
- What is SNAC in oral semaglutide?
- Alzheimer's Disease Drug Development: Aducanumab, Lecanemab & Donanemab
- Antibody–Oligonucleotide Conjugates (AOCs) in Clinical Trials
- Peptide Therapeutics: Current Status And Future Directions
- Radionuclide Drug Conjugates (RDCs): Current Status
- Development of PD-L1 Antibody Drug Conjugates (ADC)
- Recent Advances In Hematology 2022: ADCs, Bispecific Antibodies, CAR-T Cells…
